Cargando…
The genetic evolution of acral melanoma
Acral melanoma is an aggressive type of melanoma with unknown origins, arising on the sole, palm, or nail apparatus. It is the most common type of melanoma in individuals with dark skin and is notoriously challenging to treat. Our study examined exome sequencing data from 139 tissue samples, spannin...
Autores principales: | Wang, Meng, Fukushima, Satoshi, Sheen, Yi-Shuan, Ramelyte, Egle, Pacheco, Noel Cruz, Shi, Chenxu, Liu, Shanshan, Banik, Ishani, Aquino, Jamie D., Acosta, Martin Sangueza, Levesque, Mitchell, Dummer, Reinhard, Liau, Jau-Yu, Chu, Chia-Yu, Shain, A. Hunter, Yeh, Iwei, Bastian, Boris C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10614839/ https://www.ncbi.nlm.nih.gov/pubmed/37904969 http://dx.doi.org/10.1101/2023.10.18.562802 |
Ejemplares similares
-
Integrated genomic analyses of acral and mucosal melanomas nominate novel driver genes
por: Wang, Meng, et al.
Publicado: (2022) -
A clinicopathological analysis of 153 acral melanomas and the relevance of mechanical stress
por: Sheen, Yi-Shuan, et al.
Publicado: (2017) -
Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma
por: Sheen, Yi-Shuan, et al.
Publicado: (2016) -
Recurrent squamous cell carcinoma of the perianal skin: a case report
por: Staeger, Ramon, et al.
Publicado: (2020) -
The role of triple therapy and therapy sequence in treatment of BRAF-mutant metastatic melanoma. Response to overall survival with first-line atezolizumab in combination with vemurafenib and cobimetinib in BRAFV600 mutation-positive advanced melanoma (IMspire150): second interim analysis of a multicentre, randomised, phase 3 study
por: Dummer, Reinhard, et al.
Publicado: (2023)